Sign in Create account
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export announcements as CSV.

Fortis Healthcare Limited

Healthcare · Healthcare Services

NSE: FORTIS BSE: 532843
₹770.00
▼ -52.00 (-6.33%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
49/100
Moderate
Valuation
26/100
Expensive
Momentum
6/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

About

Fortis Healthcare Limited is an Indian for-profit private hospital network headquartered in Gurgaon.

Source: Wikipedia

Key Metrics

Market Capitalization
₹58,132 Cr
PE (TTM)
257.5
Industry median 50.2 (44 companies)
Price to Book
5.7
PEG (TTM)
1.7
Institutions holding %
57.43%
FII + DII, latest filed period
Piotroski Score
6
Relative return vs Nifty50, qtr %
-12.8
Relative return vs Sector, qtr %
-16.1
Free Cash Flow
₹656 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-8.70%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
154.67%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
19.63%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-7.90%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
13.03%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
0.86
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.28
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
2.32
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
9.76%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
21.69%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
25.23%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
6.67%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
12.02%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
10.47%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • Yes Debt to equity is below 0.5 (0.28)
  • No Return on equity is 15% or more (10.5%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-6.3%
Low 757.4500 · High 821.0000
1W return
-13.9%
Low 757.4500 · High 897.1500
1M return
-15.1%
Low 757.4500 · High 921.4500
52W return
-22.2%
Low 757.4500 · High 1104.3000
Lifetime High ₹1097.9000 (Oct. 21, 2025)
Lifetime Low ₹49.0500 (Oct. 10, 2008)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
820.4
10D
846.0
20D
870.0
50D
900.1
100D
912.8
200D
909.9

Delivery and volume

Day avg. delivery
52.6%
Week avg. delivery
53.6%
Month avg. delivery
56.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

782.82
Pivot
First resistance808.18
Second resistance846.37
Third resistance871.73
First support744.63
Second support719.27
Third support681.08
Day RSI18.5
Day MFI21.4
Day MACD-26.40
Day MACD signal-16.27

Beta

1M0.16
3M0.61
1Y0.81
3Y0.68

Price change analysis

↓ -15.1%
Over 1 Month
LowHigh
757.45921.45
↓ -18.9%
Over 3 Months
LowHigh
757.45996.55
↓ -3.1%
Over 6 Months
LowHigh
757.451010.10
↓ -22.2%
Over 1 Year
LowHigh
757.451104.30
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 257.5 (own history: 159.8–831.4)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹489 Cr
Net profit (June 30, 2026)
₹48 Cr
Basic EPS (June 30, 2026)
₹0.6300

Ranks #3 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter31.17%
  • Mutual funds25.81%
  • FII/FPI25.20%
  • Other DII6.42%
  • Public11.40%

Largest holders

NameCategoryShares %Shares
NORTHERN TK VENTURE PTE. LTD.Promoter31.1700%235295895
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUNDPublic6.5400%49347068
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCAREPublic5.7600%43464764
REKHA JHUNJHUNWALAPublic4.0200%30350152
AXIS MUTUAL FUND TRUSTEE LTD. A/C AXIS MUTUAL FUNDPublic2.9400%22184657

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 31.17% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 25.97% to 25.20% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 25.72% to 25.81% in Jun 2026 qtr

83 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 208 insider trades, 68 SAST, 207 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
23 Feb 2021 ASHISH BHATIA Employee / designated person Sell 0 ₹0
20 Feb 2021 ASHISH BHATIA Employee / designated person Sell 0 ₹0
20 Feb 2021 ASHISH BHATIA Employee / designated person Sell 0 ₹0
24 Jan 2019 Harinder Singh Chehal Employee / designated person Buy 0 ₹0
13 Dec 2018 ASHISH BHATIA Employee / designated person Buy 0 ₹0
10 Dec 2018 Anurag Kalra Employee / designated person Buy 0 ₹0
26 Jul 2018 MALAV HOLDINGS PVT LIMITED Promoter Sell 0 ₹0
26 Jul 2018 MALVINDER MOHAN SINGH Promoter Sell 0 ₹0
26 Jul 2018 SHIVINDER MOHAN SINGH Promoter Sell 0 ₹0
26 Jul 2018 RHC HOLDING PVT LIIMITED Promoter Sell 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 156 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
24 Nov 2025 INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD. Bulk Sell 5,281,102 921.9300 NSE
24 Nov 2025 BNP PARIBAS FINANCIAL MARKETS Bulk Sell 11,938,263 921.8500 NSE
13 Nov 2025 BNP PARIBAS FINANCIAL MARKETS Block Buy 176,393 969.4000 BSE
13 Nov 2025 GOLDMAN SACHS BANK EUROPE SE Block Sell 176,393 969.4000 BSE
12 Nov 2025 UBS AG Block Sell 509,235 975.4000 BSE
12 Nov 2025 MORGAN STANLEY ASIA (SINGAPORE) PTE. Block Buy 509,235 975.4000 BSE
7 Oct 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 219,013 1042.0000 NSE
7 Oct 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 219,013 1042.0000 NSE
22 Sep 2025 GOLDMAN SACHS (SINGAPORE) PTE Block Buy 219,013 953.9500 NSE
22 Sep 2025 AWARE SUPER Block Sell 219,013 953.9500 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹1.00 per share
Dividend yield 0.13%
Ex-dateSubjectPer share (₹)Record date
24 Jul 2026 Dividend - Re 1 Per Share 1.0000 24 Jul 2026
25 Jul 2025 Dividend - Re 1 Per Share 1.0000 25 Jul 2025
24 Jul 2024 Dividend - Re 1 Per Share 1.0000 24 Jul 2024
20 Jul 2023 Dividend - Re 1 Per Share 1.0000 20 Jul 2023

Corporate Actions

Full history (17 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from FORTIS HEALTHCARE (INDIA) LTD to Fortis Healthcare Ltd
—NAME_CHANGEName changed from FORTIS HEALTHCARE LTD. to FORTIS HEALTHCARE (INDIA) LTD
16 Sep 2016OTHER Annual General Meeting
14 Sep 2015OTHER Annual General Meeting
18 Sep 2014OTHERAnnual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
6 Aug 2026 Financial Results Yes
22 May 2026 Financial Results/Dividend Yes
13 Feb 2026 Financial Results Yes
11 Nov 2025 Financial Results Yes
6 Aug 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 1169 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 General Updates Fortis Healthcare Limited has informed the Exchange about General Updates on Announcement / Press release filed by IHH Healthcare Berhad ( IHH )
29 Sep 2026 Company Update Fortis Healthcare Ltd - 532843 - Announcement / Press Release Filed By IHH Healthcare Berhad ('IHH')
27 Sep 2026 General Updates Fortis Healthcare Limited has informed the Exchange about update on Special Leave Petition ('SLP') filed by the Company before The Hon'ble Supreme Court of India
27 Sep 2026 Company Update Fortis Healthcare Ltd - 532843 - Update On Special Leave Petition (''SLP'') Filed By The Company Before The Hon''ble Supreme Court Of India
25 Sep 2026 Trading Window Fortis Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 General Updates Fortis Healthcare Limited has informed the Exchange about General Updates on material Litigation filed by Northern TK Venture Pte Ltd. ('NTK'), the Promoter Shareholder of the Company, against Daiichi Sankyo Company, Limited before the Tokyo District Court in Japan
25 Sep 2026 Insider Trading / SAST Fortis Healthcare Ltd - 532843 - Closure of Trading Window
25 Sep 2026 Company Update Fortis Healthcare Ltd - 532843 - Update On Material Litigation Filed By Northern TK Venture Pte Ltd. (''NTK''), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company, Limited Before The Tokyo District Court In Japan
16 Sep 2026 Company Update Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
16 Sep 2026 Company Update Fortis Healthcare Ltd - 532843 - Intimation For Signing The Definitive Agreements By Fortis Hospotel Limited (Wholly Owned Subsidiary Of The Company) To Provide Healthcare Services To A 400+ Bedded Super Specialty Hospital In Ashok Vihar, New Delhi

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.28)

Weaknesses

  • Tight liquidity (Current Ratio 0.86)
  • Declining profit YoY (-7.9%)

Opportunities

  • RSI in oversold territory (18.5) -- a technical rebound zone

Threats

  • PE above 35 (257.5) -- priced for continued strong execution
  • Down 22.2% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Single-stock futures and a real listed options chain available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.

Part of: NIFTY 200, NIFTY 200, NIFTY 500, NIFTY 500, NIFTY MIDCAP 100, NIFTY MIDCAP 100, NIFTY MIDCAP 150, NIFTY MIDCAP 150, NIFTY MIDCAP 50, NIFTY MIDCAP 50

Frequently asked questions about Fortis Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.